BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lanteri MC, Santa-Maria F, Laughhunn A, Girard YA, Picard-Maureau M, Payrat JM, Irsch J, Stassinopoulos A, Bringmann P. Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light. Transfusion 2020;60:1319-31. [PMID: 32333396 DOI: 10.1111/trf.15807] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Sow C, Bouissou A, Girard YA, Singh GB, Bounaadja L, Payrat JM, Haas D, Isola H, Lanteri MC, Bringmann P, Grellier P. Robust inactivation of Plasmodium falciparum in red blood cell concentrates using amustaline and glutathione pathogen reduction. Transfusion 2022. [PMID: 35385146 DOI: 10.1111/trf.16867] [Reference Citation Analysis]
2 Focosi D, Franchini M. Impact of pathogen-reduction technologies on COVID-19 convalescent plasma potency. Transfus Clin Biol 2021;28:132-4. [PMID: 33675992 DOI: 10.1016/j.tracli.2021.02.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Morio KA, Sternowski RH, Brogden KA. Using ultraviolet (UV) light emitting diodes (LED) to create sterile root canals and to treat endodontic infections. Current Opinion in Biomedical Engineering 2022. [DOI: 10.1016/j.cobme.2022.100397] [Reference Citation Analysis]
4 Hindawi SI, El-Kafrawy SA, Hassan AM, Badawi MA, Bayoumi MM, Almalki AA, Zowawi HM, Tolah AM, Alandijany TA, Abunada Q, Picard-Maureau M, Damanhouri GA, Azhar EI. Efficient inactivation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in human apheresis platelet concentrates with amotosalen and ultraviolet A light. Transfus Clin Biol 2021:S1246-7820(21)00119-1. [PMID: 34411748 DOI: 10.1016/j.tracli.2021.08.005] [Reference Citation Analysis]
5 Azhar EI, Hindawi SI, El-Kafrawy SA, Hassan AM, Tolah AM, Alandijany TA, Bajrai LH, Damanhouri GA. Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human plasma. Vox Sang 2021;116:673-81. [PMID: 33277935 DOI: 10.1111/vox.13043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Fan B, Yi M, Yang G, Yang L, Shang W, Liu Y, Zhong X, Zhu L, Wang D. Expanded validation of the effect and quality of a pathogen inactivation system based on riboflavin photochemistry on platelet bacterial contamination. Ann Transl Med 2021;9:1736. [PMID: 35071430 DOI: 10.21037/atm-21-5834] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hsien S, Dayton JD, Chen D, Stock A, Bacha E, Cushing MM, Nellis ME. Hemostatic efficacy of pathogen-reduced platelets in children undergoing cardiopulmonary bypass. Transfusion 2021. [PMID: 34904250 DOI: 10.1111/trf.16768] [Reference Citation Analysis]
8 Olschewski S, Thielebein A, Hoffmann C, Blake O, Müller J, Bockholt S, Pallasch E, Hinzmann J, Wurr S, Neddersen N, Rieger T, Günther S, Oestereich L. Validation of Inactivation Methods for Arenaviruses. Viruses 2021;13:968. [PMID: 34073735 DOI: 10.3390/v13060968] [Reference Citation Analysis]
9 Escolar G, Diaz-Ricart M, McCullough J. Impact of different pathogen reduction technologies on the biochemistry, function, and clinical effectiveness of platelet concentrates: An updated view during a pandemic. Transfusion 2021. [PMID: 34870335 DOI: 10.1111/trf.16747] [Reference Citation Analysis]
10 He Y, Xu F, Ibrahim Z, Feyissa Q, Reed JL, Vostal JG. Viral reduction of human blood by ultraviolet A-photosensitized vitamin K5. J Med Virol 2021;93:5134-40. [PMID: 33837954 DOI: 10.1002/jmv.27008] [Reference Citation Analysis]
11 Capraru A, Jalowiec KA, Medri C, Daskalakis M, Zeerleder SS, Mansouri Taleghani B. Platelet Transfusion-Insights from Current Practice to Future Development. J Clin Med 2021;10:1990. [PMID: 34066360 DOI: 10.3390/jcm10091990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Bubinski M, Gronowska A, Szykula P, Kluska K, Kuleta I, Ciesielska E, Picard-Maureau M, Lachert E. Plasma pooling in combination with amotosalen/UVA pathogen inactivation to increase standardisation and safety of therapeutic plasma units. Transfus Med 2021;31:136-41. [PMID: 33686720 DOI: 10.1111/tme.12763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Feyissa Q, Xu F, Ibrahim Z, Li Y, Xu KL, Guo Z, Ahmad J, Vostal JG. Synergistic bactericidal effects of pairs of photosensitizer molecules activated by ultraviolet A light against bacteria in plasma. Transfusion 2021;61:594-602. [PMID: 33219568 DOI: 10.1111/trf.16180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Wendel S, Kutner JM, Machado R, Fontão-Wendel R, Bub C, Fachini R, Yokoyama A, Candelaria G, Sakashita A, Achkar R, Hamerschlak N, Scuracchio P, Amaral M, Dal Ben M, Araujo D, Soares C, Camargo A, Kallás E, Durigon E, Reis LF, Rizzo LV. Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program. Transfusion 2020;60:2938-51. [PMID: 32935877 DOI: 10.1111/trf.16065] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
15 Santa Maria F, Huang YS, Vanlandingham DL, Bringmann P. Inactivation of SARS-CoV-2 in All Blood Components Using Amotosalen/Ultraviolet A Light and Amustaline/Glutathione Pathogen Reduction Technologies. Pathogens 2022;11:521. [DOI: 10.3390/pathogens11050521] [Reference Citation Analysis]
16 Fachini RM, Fontão-Wendel R, Achkar R, Scuracchio P, Brito M, Amaral M, Wendel S. The 4-Year Experience with Implementation and Routine Use of Pathogen Reduction in a Brazilian Hospital. Pathogens 2021;10:1499. [PMID: 34832654 DOI: 10.3390/pathogens10111499] [Reference Citation Analysis]
17 Fridey JL, Stramer SL, Nambiar A, Moayeri M, Bakkour S, Langelier C, Crawford E, Lu T, Lanteri MC, Kamm J, Miller S, Wagner SJ, Benjamin RJ, Busch MP. Sepsis from an apheresis platelet contaminated with Acinetobacter calcoaceticus/baumannii complex bacteria and Staphylococcus saprophyticus after pathogen reduction. Transfusion 2020;60:1960-9. [PMID: 32738079 DOI: 10.1111/trf.15951] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]